Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
A concise checklist to evaluate crypto whitepapers, covering goals, roadmap realism, team capabilities, and risk factors for smarter decisions.
16,547 articlesA large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
A six-year Wharton study links leader narcissism to resistance to remote work. The research suggests Fortune 500 boss...
Strategy (formerly MicroStrategy) appears poised to complete its 100th Bitcoin purchase, signaling a bold continuatio...
The MORT ETF offers a double-digit yield, but its payout hinges on the health of its mortgage REIT holdings. This art...
New real estate investors often hit a wall when income is inconsistent. DSCR loans offer a financing strategy grounde...
Tesla sits at a fair-value crossroads in 2026, with capex and AI initiatives guiding a modest upside. Here’s how inve...
A new wave of tariff talk harkens back to a controversial era. This piece explains why trump’s tariffs: lesson econom...
President Trump pushes the DOJ to investigate alleged price gouging by major oil firms, citing pump prices while dono...
Private exits are lagging as liquidity tightens in private markets. This report explains why the exploding secondarie...
A growing share of U.S. spending now comes from the top 20% of households, raising questions about the resilience of ...
A caller on The Ramsey Show turned $270K into $1.1M in three years, driven by four stock bets. Ramsey cautions that s...
Moderna led a broad vaccine stock rally, rising about 14% as investors priced in pipeline momentum and favorable regu...